Ovarian Cancer Clinical Trials

Clinical Trial: Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

Clinical Trial: Data Collection for Patients With Low Grade Ovarian Carcinoma

Clinical Trial: Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer

Clinical Trial: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

Clinical Trial: Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer

Clinical Trial: Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer

Clinical Trial: A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

Clinical Trial: Screening Methods for Finding Ovarian Cancer

Clinical Trial: Study of Individuals and Families at High Risk for Breast or Ovarian Cancer

Clinical Trial: M. D. Anderson Symptom Inventory - Ovarian Cancer

For a complete listing of clinical trials pertaining to Ovarian Cancer via ClinicalTrials.gov, click here.

Ovarian Cancer News

BRCA Carriers Have Improved Survival in Ovarian Cancer

Bevacizumab delays return of ovarian cancer

Genetic variation in ovarian cancer thwarts treatment

Fluorescence-guided surgery puts ovarian cancer in a new light

PARP inhibitor found effective in women without BRCA mutation

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets
ONA Newsletters
Sign up today for one of our free newsletters:
  • Issue Preview
  • Latest CE
  • Reflections
  • Editor's choice
  • New on the Web

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions